Literature DB >> 12620406

p27 as a target for cancer therapeutics.

Stacy W Blain1, Howard I Scher, Carlos Cordon-Cardo, Andrew Koff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12620406     DOI： 10.1016/s1535-6108(03)00026-6

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


× No keyword cloud information.
  40 in total

1.  XMRV accelerates cellular proliferation, transformational activity, and invasiveness of prostate cancer cells by downregulating p27(Kip1).

Authors:  Jui Pandhare-Dash; Chinmay K Mantri; Yuanying Gong; Zhenbang Chen; Chandravanu Dash
Journal:  Prostate       Date:  2011-09-19       Impact factor: 4.104

2.  Stat1 stimulates cap-independent mRNA translation to inhibit cell proliferation and promote survival in response to antitumor drugs.

Authors:  Shuo Wang; Christos Patsis; Antonis E Koromilas
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-13       Impact factor: 11.205

3.  Evidence for a p27 tumor suppressive function independent of its role regulating cell proliferation in the prostate.

Authors:  David R Shaffer; Agnes Viale; Ryota Ishiwata; Margaret Leversha; Semra Olgac; Katia Manova; Jaya Satagopan; Howard Scher; Andrew Koff
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-22       Impact factor: 11.205

4.  Effect of p27(KIP1) on cell cycle and apoptosis in gastric cancer cells.

Authors:  Jian-Yong Zheng; Wei-Zhong Wang; Kai-Zong Li; Wen-Xian Guan; Wei Yan
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

Review 5.  Deregulation of cell signaling in cancer.

Authors:  Filippo G Giancotti
Journal:  FEBS Lett       Date:  2014-02-20       Impact factor: 4.124

6.  Evidence for PTEN-independent Akt activation and Akt-independent p27(Kip1) expression in advanced bladder cancer.

Authors:  J Mundhenk; J Hennenlotter; L Zug; S H Alloussi; T Todenhoefer; G Gakis; S Aufderklamm; M Scharpf; U Kuehs; A Stenzl; C Schwentner
Journal:  Oncol Lett       Date:  2011-08-05       Impact factor: 2.967

7.  Cyclin D1 predicts the prognosis of advanced serous ovarian cancer.

Authors:  Tomoko Hashimoto; Nozomu Yanaihara; Aikou Okamoto; Takashi Nikaido; Misato Saito; Satoshi Takakura; Makoto Yasuda; Hiroshi Sasaki; Kazunori Ochiai; Tadao Tanaka
Journal:  Exp Ther Med       Date:  2011-01-18       Impact factor: 2.447

8.  Diazoxide promotes oligodendrocyte precursor cell proliferation and myelination.

Authors:  Birgit Fogal; Carolyn McClaskey; Sha Yan; Henglin Yan; Scott A Rivkees
Journal:  PLoS One       Date:  2010-05-28       Impact factor: 3.240

9.  A coumarin derivative (RKS262) inhibits cell-cycle progression, causes pro-apoptotic signaling and cytotoxicity in ovarian cancer cells.

Authors:  Rakesh K Singh; Thilo S Lange; Kyu Kwang Kim; Laurent Brard
Journal:  Invest New Drugs       Date:  2009-10-29       Impact factor: 3.850

10.  Defective DNA double-strand break repair underlies enhanced tumorigenesis and chromosomal instability in p27-deficient mice with growth factor-induced oligodendrogliomas.

Authors:  W L See; J P Miller; M Squatrito; E Holland; M D Resh; A Koff
Journal:  Oncogene       Date:  2010-01-11       Impact factor: 9.867
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.